News
- Almaprism Inc. raises 150 million yen in funding
- Original investigation: executive functions can be assessed comprehensively in ADHD children and adolescents using a 3-D video game
- Almaprism received HVC Kyoto 2024’s JETRO Award.
- Almaprism has been registered as a medical device manufacturer.
- Almaprism presented at the “Tozai Science Park DAY 2024” in Kanagawa
- Almaprism selected for A-rank certification by City of Kyoto Startup”Mekiki” Committee
- Research findings presented at the 15th Meeting of the Japan Society for ADHD
- Almaprism selected for Social and Sustainable business standard
- Almaprism CEO Shinichi Kasuno receives Award of Excellence at the 10th Kyoto Shinkin Bank/Community Entrepreneurship Award
- Video Game for the Treatment of ADHD receives AMED Grant for the Research and Development of New Medical Devices
Research Highlights
- Original investigation: executive functions can be assessed comprehensively in ADHD children and adolescents using a 3-D video game
- Research findings presented at the 15th Meeting of the Japan Society for ADHD
- Video Game for the Treatment of ADHD receives AMED Grant for the Research and Development of New Medical Devices
